Listed

OnKure Therapeutics, Inc.

OKURNasdaqCIK 1637715HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$16.9m, Q2 FY2026
Net income−$15.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m13.6Research and development, Q3 FY2023, three months to 2023-09-30$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figure(6.9)Research and development, Q4 FY2023, three months to 2023-12-31−$6.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-10, accession 0000950170-25-036252. Derived: 12-month figure less the 9-month figure.Report this figure8.6Research and development, Q1 FY2024, three months to 2024-03-31$8.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure10.8Research and development, Q2 FY2024, three months to 2024-06-30$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001193125-25-178981.Report this figure10.1Research and development, Q3 FY2024, three months to 2024-09-30$10.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure14.4Research and development, Q4 FY2024, three months to 2024-12-31$14.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104147. Derived: 12-month figure less the 9-month figure.Report this figure13.0Research and development, Q1 FY2025, three months to 2025-03-31$13.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure12.6Research and development, Q2 FY2025, three months to 2025-06-30$12.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure11.9Research and development, Q3 FY2025, three months to 2025-09-30$11.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure10.7Research and development, Q4 FY2025, three months to 2025-12-31$10.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104147. Derived: 12-month figure less the 9-month figure.Report this figure11.7Research and development, Q1 FY2026, three months to 2026-03-31$11.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure12.6Research and development, Q2 FY2026, three months to 2026-06-30$12.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure
Operating income$m(20.9)Operating income, Q3 FY2023, three months to 2023-09-30−$20.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figure21.1Operating income, Q4 FY2023, three months to 2023-12-31$21.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-10, accession 0000950170-25-036252. Derived: 12-month figure less the 9-month figure.Report this figure(9.8)Operating income, Q1 FY2024, three months to 2024-03-31−$9.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure(14.3)Operating income, Q2 FY2024, three months to 2024-06-30−$14.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001193125-25-178981.Report this figure(11.5)Operating income, Q3 FY2024, three months to 2024-09-30−$11.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure(18.7)Operating income, Q4 FY2024, three months to 2024-12-31−$18.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104147. Derived: 12-month figure less the 9-month figure.Report this figure(17.0)Operating income, Q1 FY2025, three months to 2025-03-31−$17.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure(16.3)Operating income, Q2 FY2025, three months to 2025-06-30−$16.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure(15.5)Operating income, Q3 FY2025, three months to 2025-09-30−$15.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure(14.1)Operating income, Q4 FY2025, three months to 2025-12-31−$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104147. Derived: 12-month figure less the 9-month figure.Report this figure(15.6)Operating income, Q1 FY2026, three months to 2026-03-31−$15.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure(16.9)Operating income, Q2 FY2026, three months to 2026-06-30−$16.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure
Net income$m(19.2)Net income, Q3 FY2023, three months to 2023-09-30−$19.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figure18.5Net income, Q4 FY2023, three months to 2023-12-31$18.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-10, accession 0000950170-25-036252. Derived: 12-month figure less the 9-month figure.Report this figure(9.5)Net income, Q1 FY2024, three months to 2024-03-31−$9.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure(14.1)Net income, Q2 FY2024, three months to 2024-06-30−$14.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure(11.6)Net income, Q3 FY2024, three months to 2024-09-30−$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure(17.4)Net income, Q4 FY2024, three months to 2024-12-31−$17.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure(15.9)Net income, Q1 FY2025, three months to 2025-03-31−$15.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure(15.4)Net income, Q2 FY2025, three months to 2025-06-30−$15.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure(14.7)Net income, Q3 FY2025, three months to 2025-09-30−$14.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure(13.5)Net income, Q4 FY2025, three months to 2025-12-31−$13.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure(15.2)Net income, Q1 FY2026, three months to 2026-03-31−$15.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure(15.3)Net income, Q2 FY2026, three months to 2026-06-30−$15.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure
Diluted EPS$ per share(5.68)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$5.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figurenot reported(30.37)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$30.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure(44.82)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$44.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001193125-25-178981.Report this figure(36.55)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$36.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figurenot reported(1.19)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure(1.14)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure(1.09)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figurenot reported(1.11)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure(0.31)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure
Basic EPS$ per share(5.68)Basic EPS, Q3 FY2023, three months to 2023-09-30−$5.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figurenot reported(30.37)Basic EPS, Q1 FY2024, three months to 2024-03-31−$30.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure(44.82)Basic EPS, Q2 FY2024, three months to 2024-06-30−$44.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001193125-25-178981.Report this figure(36.55)Basic EPS, Q3 FY2024, three months to 2024-09-30−$36.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figurenot reported(1.19)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure(1.14)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure(1.09)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figurenot reported(1.11)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure(0.31)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure

Balance sheet

Cash and equivalents$166.5m, Q2 FY2026
Shareholders' equity$172.1m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m11.7Cash and equivalents, Q3 FY2023, at 2023-09-30$11.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0000950170-23-062910.Report this figure29.9Cash and equivalents, FY2023, at 2023-12-31$29.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-10, accession 0000950170-25-036252.Report this figure20.4Cash and equivalents, Q1 FY2024, at 2024-03-31$20.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0000950170-24-054452.Report this figure36.0Cash and equivalents, Q2 FY2024, at 2024-06-30$36.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0000950170-24-096411.Report this figure60.7Cash and equivalents, Q3 FY2024, at 2024-09-30$60.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figure111Cash and equivalents, FY2024, at 2024-12-31$110.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001193125-26-104147.Report this figure96.7Cash and equivalents, Q1 FY2025, at 2025-03-31$96.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure83.4Cash and equivalents, Q2 FY2025, at 2025-06-30$83.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001193125-25-178981.Report this figure70.3Cash and equivalents, Q3 FY2025, at 2025-09-30$70.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure59.1Cash and equivalents, FY2025, at 2025-12-31$59.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure192Cash and equivalents, Q1 FY2026, at 2026-03-31$192.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure167Cash and equivalents, Q2 FY2026, at 2026-06-30$166.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure
Current assets$m129Current assets, Q3 FY2023, at 2023-09-30$128.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062910.Report this figure33.8Current assets, FY2023, at 2023-12-31$33.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-10, accession 0000950170-25-036252.Report this figure83.9Current assets, Q1 FY2024, at 2024-03-31$83.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054452.Report this figure78.0Current assets, Q2 FY2024, at 2024-06-30$78.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096411.Report this figure77.0Current assets, Q3 FY2024, at 2024-09-30$77.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figure113Current assets, FY2024, at 2024-12-31$113.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104147.Report this figure98.2Current assets, Q1 FY2025, at 2025-03-31$98.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure84.6Current assets, Q2 FY2025, at 2025-06-30$84.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001193125-25-178981.Report this figure71.5Current assets, Q3 FY2025, at 2025-09-30$71.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure60.8Current assets, FY2025, at 2025-12-31$60.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure197Current assets, Q1 FY2026, at 2026-03-31$197.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure178Current assets, Q2 FY2026, at 2026-06-30$177.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure
Total assets$m130Total assets, Q3 FY2023, at 2023-09-30$130.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0000950170-23-062910.Report this figure35.7Total assets, FY2023, at 2023-12-31$35.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-10, accession 0000950170-25-036252.Report this figure84.6Total assets, Q1 FY2024, at 2024-03-31$84.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0000950170-24-054452.Report this figure78.7Total assets, Q2 FY2024, at 2024-06-30$78.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-096411.Report this figure77.6Total assets, Q3 FY2024, at 2024-09-30$77.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figure115Total assets, FY2024, at 2024-12-31$114.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001193125-26-104147.Report this figure99.9Total assets, Q1 FY2025, at 2025-03-31$99.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure86.1Total assets, Q2 FY2025, at 2025-06-30$86.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001193125-25-178981.Report this figure72.8Total assets, Q3 FY2025, at 2025-09-30$72.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure62.1Total assets, FY2025, at 2025-12-31$62.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure199Total assets, Q1 FY2026, at 2026-03-31$198.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure179Total assets, Q2 FY2026, at 2026-06-30$179.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure
Current liabilities$m13.6Current liabilities, Q3 FY2023, at 2023-09-30$13.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062910.Report this figure7.3Current liabilities, FY2023, at 2023-12-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-10, accession 0000950170-25-036252.Report this figure2.8Current liabilities, Q1 FY2024, at 2024-03-31$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054452.Report this figure1.3Current liabilities, Q2 FY2024, at 2024-06-30$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096411.Report this figure3.2Current liabilities, Q3 FY2024, at 2024-09-30$3.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figure10.5Current liabilities, FY2024, at 2024-12-31$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104147.Report this figure8.8Current liabilities, Q1 FY2025, at 2025-03-31$8.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure7.6Current liabilities, Q2 FY2025, at 2025-06-30$7.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001193125-25-178981.Report this figure6.2Current liabilities, Q3 FY2025, at 2025-09-30$6.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure5.9Current liabilities, FY2025, at 2025-12-31$5.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure14.3Current liabilities, Q1 FY2026, at 2026-03-31$14.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure6.6Current liabilities, Q2 FY2026, at 2026-06-30$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure
Total liabilities$m15.4Total liabilities, Q3 FY2023, at 2023-09-30$15.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0000950170-23-062910.Report this figure7.8Total liabilities, FY2023, at 2023-12-31$7.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-10, accession 0000950170-25-036252.Report this figure3.4Total liabilities, Q1 FY2024, at 2024-03-31$3.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0000950170-24-054452.Report this figure1.8Total liabilities, Q2 FY2024, at 2024-06-30$1.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-096411.Report this figure3.6Total liabilities, Q3 FY2024, at 2024-09-30$3.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figure11.1Total liabilities, FY2024, at 2024-12-31$11.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001193125-26-104147.Report this figure9.2Total liabilities, Q1 FY2025, at 2025-03-31$9.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure7.9Total liabilities, Q2 FY2025, at 2025-06-30$7.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001193125-25-178981.Report this figure6.4Total liabilities, Q3 FY2025, at 2025-09-30$6.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure5.9Total liabilities, FY2025, at 2025-12-31$5.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure14.3Total liabilities, Q1 FY2026, at 2026-03-31$14.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure7.2Total liabilities, Q2 FY2026, at 2026-06-30$7.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure
Shareholders' equity$m115Shareholders' equity, Q3 FY2023, at 2023-09-30$114.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figure(102)Shareholders' equity, FY2023, at 2023-12-31−$101.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001193125-26-104147.Report this figure(111)Shareholders' equity, Q1 FY2024, at 2024-03-31−$111.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure(124)Shareholders' equity, Q2 FY2024, at 2024-06-30−$123.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure(135)Shareholders' equity, Q3 FY2024, at 2024-09-30−$135.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure104Shareholders' equity, FY2024, at 2024-12-31$103.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure90.6Shareholders' equity, Q1 FY2025, at 2025-03-31$90.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure78.2Shareholders' equity, Q2 FY2025, at 2025-06-30$78.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure66.4Shareholders' equity, Q3 FY2025, at 2025-09-30$66.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure56.2Shareholders' equity, FY2025, at 2025-12-31$56.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure184Shareholders' equity, Q1 FY2026, at 2026-03-31$184.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure172Shareholders' equity, Q2 FY2026, at 2026-06-30$172.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure

Cash flow

Operating cash flow−$10.4m, Q2 FY2026
Capital expenditure$3.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(18.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$18.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123233. Derived: 9-month figure less the 6-month figure.Report this figure9.4Operating cash flow, Q4 FY2023, three months to 2023-12-31$9.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-10, accession 0000950170-25-036252. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure(6.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001193125-25-178981. Derived: 6-month figure less the 3-month figure.Report this figure(10.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269540. Derived: 9-month figure less the 6-month figure.Report this figure(23.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$23.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104147. Derived: 12-month figure less the 9-month figure.Report this figure(14.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure(13.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-332773. Derived: 6-month figure less the 3-month figure.Report this figure(13.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269540. Derived: 9-month figure less the 6-month figure.Report this figure(11.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$11.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104147. Derived: 12-month figure less the 9-month figure.Report this figure(12.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$12.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure(10.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$10.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-332773. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123233. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$50.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-10, accession 0000950170-25-036252. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001193125-25-178981. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269540. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-104147. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001193125-26-332773. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269540. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-104147. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001193125-26-332773. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)49.87m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares24.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3024,496,313 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0000950170-23-062910.Report this figure25.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3125,036,410 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0000950170-24-054452.Report this figure30.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3030,215,321 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096411.Report this figure3.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-303,380,794 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123233.Report this figure0.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31314,016 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-063970.Report this figure0.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30315,478 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001193125-25-178981.Report this figure0.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30316,142 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure13.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3113,424,335 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure13.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3013,509,080 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure13.5Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3013,530,892 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269540.Report this figure13.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3113,674,577 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-206345.Report this figure49.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3049,869,177 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure

Shares outstanding: 40.50mShares outstanding, period not labelled, at 2026-08-0340,496,309 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332773.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.